HBM collaborates with Viva Biotech to promote biotech start-ups

  Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company based in the US and Shanghai-based Viva ...

August 5, 2020 | Wednesday | News
G1, Simcere to bring new cancer therapy in Greater China

US based G1 Therapeutics, Inc., a clinical-stage oncology company, and Simcere Pharmaceutical Group, a pharmaceutic...

August 6, 2020 | Thursday | News
Innovent announces first patient dosed in Ph 1 clinical trial of bispecific antibody

Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical Chinese company that develops, manufactures and com...

August 3, 2020 | Monday | News
Gan & Lee launches first Ph I clinical trial for new anti-tumor drug

Recently, Chinese company Gan & Lee Pharmaceuticals Co., Ltd. (Gan & Lee), has launched their first Phase 1 huma...

July 31, 2020 | Friday | News
Hisun's Favipiravir supports Middle East in fighting COVID-19

  According to the Middle East News Agency, Favipiravir, the popular drug used for treating COVID-19 has shown exc...

July 31, 2020 | Friday | News
Viva Biotech, Schrödinger focus on structure-based drug discovery

China based Viva Biotech Holdings and Schrödinger, Inc. in the US have announced a strategic collaboration to ...

July 31, 2020 | Friday | News
Henlius & Accord Healthcare receives EMA approval for Zercepac®

The European Commission (EC) has approved Shanghai-based Henlius Biotech, Inc. and Accord Healthcare Limited (Accor...

July 30, 2020 | Thursday | News
AAIC indicates new breakthrough in Alzheimer's research

Alzheimer's Association International Conference (AAIC), the largest and most influential international conference on de...

July 29, 2020 | Wednesday | News
Henlius, Accord receive EMA approval for Zercepac®, trastuzumab biosimilar

Shanghai Henlius Biotech, Inc. announced that Marketing Authorization Application (“MAA”) for HLX02 (trastuz...

July 29, 2020 | Wednesday | News
Ping An inks agreement with Shionogi to launch joint ventures

Ping An Insurance (Group) Company of China, Ltd. is pleased to announce that agreements have been signed with ...

July 28, 2020 | Tuesday | News
Chinese CRO firm Hangzhou Tigermed consulting to raise $1 billion

Chinese clinical trial and research firm Hangzhou Tigermed consulting is initiating fundraising of at least $1 billion i...

July 24, 2020 | Friday | News
Hong Kong's CU Medicine team improves Prediction of Survival in Multiple Cancer Types

A study, conducted by the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine), has identifi...

July 23, 2020 | Thursday | News
NBQ moves ahead with transformative treatment for brain cancers

A Chinese clinical-stage biopharmaceutical company, N.B. Quadriga (NBQ), developing transformative medicines for brain c...

July 24, 2020 | Friday | News
Hansoh announces strategic collaboration with EQRx for almonertinib

Shanghai-based Hansoh Pharmaceutical Group Company Ltd., a leading biopharmaceutical company has recently announced a st...

July 24, 2020 | Friday | News
COVID-19 Vaccines Test Safe & Effective by China & UK teams: the Lancet

The two leading vaccine candidates CanSinoBIO of China and AZD1222 of UK have proven the safety and efficacy a...

July 24, 2020 | Friday | News
Ascentage Pharma doses first patient with APG-115

Ascentage Pharma, a globally focused biotechnology company engaged in developing novel therapies for cancers, chronic he...

July 23, 2020 | Thursday | News
Antengene secures $97M to support ongoing drug development

Chinese startup Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company de...

July 22, 2020 | Wednesday | News
CanSino first with Ph II COVID-19 vaccine results

CanSino Biologics Inc., an innovative biopharmaceutical company dedicated to vaccine R&D and commercialization, has ...

July 21, 2020 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls